Dariusz Pytel

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Systematic Review

Cataract Surgery

Endoplasmic Reticulum

Top Venues

International journal of molecular sciences

Cancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Wioletta Rozpedek-Kaminska, Grzegorz Galita, Kamil Saramowicz, Zuzanna Granek, Julia Barczuk, Natalia Siwecka, Dariusz Pytel, Ireneusz Majsterek
Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal Astrocytes. International journal of molecular sciences 25 (2) (2024)
Wioletta Rozpedek-Kaminska, Grzegorz Galita, Kamil Saramowicz, Zuzanna Granek, Julia Barczuk, Natalia Siwecka, Dariusz Pytel, Ireneusz Majsterek
Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal Astrocytes. International journal of molecular sciences 25 (2) (2024)
Wioletta Rozpedek-Kaminska, Grzegorz Galita, Kamil Saramowicz, Zuzanna Granek, Julia Barczuk, Natalia Siwecka, Dariusz Pytel, Ireneusz Majsterek
Evaluation of the LDN-0060609 PERK Inhibitor as a Selective Treatment for Primary Open-Angle Glaucoma: An In Vitro Study on Human Retinal Astrocytes. International journal of molecular sciences 25 (2) (2024)
Paramita Chakraborty, Rasesh Y Parikh, Seungho Choi, Danh Tran, Monika Gooz, Zachariah T Hedley, Do-Sung Kim, Dariusz Pytel, Inhong Kang, Satish N Nadig, Gyda C Beeson, Lauren E Ball, Meenal Mehrotra, Hongjun Wang, Stefano Berto, Viswanathan Palanisamy, Hong Li, Shilpak Chatterjee, Paulo C Rodriguez, Eduardo N Maldonado, J Alan Diehl, Vamsi K Gangaraju, Shikhar Mehrotra
Carbon Monoxide Activates PERK-Regulated Autophagy to Induce Immunometabolic Reprogramming and Boost Antitumor T-cell Function. Cancer research 82 (10) (2022)